Xiaotong Li

1.4k total citations · 1 hit paper
72 papers, 788 citations indexed

About

Xiaotong Li is a scholar working on Pharmacology, Epidemiology and Molecular Biology. According to data from OpenAlex, Xiaotong Li has authored 72 papers receiving a total of 788 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pharmacology, 11 papers in Epidemiology and 10 papers in Molecular Biology. Recurrent topics in Xiaotong Li's work include Food Allergy and Anaphylaxis Research (4 papers), Drug-Induced Adverse Reactions (4 papers) and Pneumonia and Respiratory Infections (4 papers). Xiaotong Li is often cited by papers focused on Food Allergy and Anaphylaxis Research (4 papers), Drug-Induced Adverse Reactions (4 papers) and Pneumonia and Respiratory Infections (4 papers). Xiaotong Li collaborates with scholars based in China, United States and France. Xiaotong Li's co-authors include Makhloufi Zoulikha, Wei He, Yanmin Ju, George Frimpong Boafo, Kosheli Thapa Magar, Suodi Zhai, Nan Yao, Huilin Tang, Wenyu Hu and Shoumeng Yan and has published in prestigious journals such as Blood, PLoS ONE and Analytical Chemistry.

In The Last Decade

Xiaotong Li

67 papers receiving 773 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Multifunctional nanoparticle-mediated combining therapy for human diseases

2024 246 citations Xiaotong Li, Makhloufi Zoulikha et al. Signal Transduction and Targeted Therapy profile →

Peers

Countries citing papers authored by Xiaotong Li

Since Specialization

Citations

This map shows the geographic impact of Xiaotong Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaotong Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaotong Li more than expected).

Fields of papers citing papers by Xiaotong Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaotong Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaotong Li. The network helps show where Xiaotong Li may publish in the future.

Co-authorship network of co-authors of Xiaotong Li

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaotong Li. A scholar is included among the top collaborators of Xiaotong Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaotong Li. Xiaotong Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Sonrotoclax (BGB-11417) monotherapy in patients with Relapsed/Refractory (R/R) Mantle Cell Lymphoma (MCL) previously treated with a bruton tyrosine kinase (BTK) inhibitor: Early results from A phase 1/2 study 2025 ·Blood ·Michael Wang, Yuqin Song, Olivier Hermine, Yue-Rong Shuang, Wojciech Jurczak, (unknown), (unknown), Muhıt Özcan, Ron D. Jachimowicz, Tianlei Chen, Elena P. Ivanova, Xiaotong Li, Gabriel Man, Priscille Bourquelot, Remus Vezan, Toby A. Eyre	0
2	Combined ROS Responsive Polydopamine-Coated Berberine Nanoparticles Effective Against Ulcerative Colitis in Mouse Model 2024 ·International Journal of Nanomedicine ·(unknown), Heng Liu, Xiaotong Li, Dandan Song, Yue Liu, Chang Lu, (unknown), Huiling Chen, (unknown), Weidong Li, Xiaobin Jia, Zhipeng Chen, Rui Chen	16
3	Metformin for sepsis-associated AKI: a protocol for the Randomized Clinical Trial of the Safety and FeasibiLity of Metformin as a Treatment for sepsis-associated AKI (LiMiT AKI) 2024 ·BMJ Open ·(unknown), (unknown), David T. Huang, Sandra L. Kane‐Gill, Ryan Rivosecchi, Sruti Shiva, Thomas D. Nolin, Xinlei Chen, (unknown), Chung‐Chou H. Chang, Xiaotong Li, John A. Kellum, Hernando Gómez	5
4	Development of aptamer-based lateral flow devices for rapid detection of SARS-CoV-2 S protein and uncertainty assessment 2024 ·Talanta ·(unknown), Lianhui Zhao, Xiaotong Li, Yunhua Gao, (unknown), (unknown), Yiyang Dong	6
5	Part 2: Drug Interactions Involving Cannabis Products in Persons Aged 18 and Over: A Summary of Published Case Reports and Analysis of the FDA Adverse Event Reporting System 2024 ·Pharmacology Research & Perspectives ·(unknown), Sandra L. Kane‐Gill, Xiaotong Li, (unknown), (unknown), Susan Egbert, Mary F. Paine, Richard D. Boyce	1
6	Multifunctional nanoparticle-mediated combining therapy for human diseases breakdown → 2024 ·Signal Transduction and Targeted Therapy ·Xiaotong Li, (unknown), Makhloufi Zoulikha, George Frimpong Boafo, Kosheli Thapa Magar, Yanmin Ju, Wei He	246
7	Part 1: Evaluation of Pediatric Cannabis–Drug Interaction Reports 2024 ·Pharmacology Research & Perspectives ·(unknown), Sandra L. Kane‐Gill, Xiaotong Li, (unknown), (unknown), Susan Egbert, Mary F. Paine, Richard D. Boyce	1
8	Topological Organization of the Brain Network in Patients with Primary Angle-closure Glaucoma Through Graph Theory Analysis 2024 ·Brain Topography ·(unknown), Xiaotong Li, Xin Huang	2
9	Chat GPT-4 significantly surpasses GPT-3.5 in drug information queries 2023 ·Journal of Telemedicine and Telecare ·Na He, Yingying Yan, Ziyang Wu, Yinchu Cheng, Fang Liu, Xiaotong Li, Suodi Zhai	31
10	Vision impairment, hearing impairment and functional Limitations of subjective cognitive decline: a population-based study 2023 ·BMC Geriatrics ·(unknown), Xiaotong Li, (unknown), Yuxiang Wang, Xuhan Wang, Jing Li, (unknown), Nan Yao, Yixue Yang, Bo Li, Lina Jin	9
11	Association between selenium intake and migraine: a nationwide cross-sectional study 2023 ·Frontiers in Neuroscience ·(unknown), (unknown), Xiaotong Li, (unknown)	5
12	t(11;14) status is stable between diagnosis and relapse, and concordant between detection methodologies based on fluorescence <i>in situ</i> hybridization and next-generation sequencing in patients with multiple myeloma 2023 ·Haematologica ·Hervé Avet‐Loiseau, (unknown), Xiaotong Li, Jeremy A. Ross, Carlos Hader	2
13	Plasma ApoB/AI: An effective indicator for intracranial vascular positive remodeling 2022 ·Journal of the Neurological Sciences ·Shi Wang, Zhenfei Li, Xiaotong Li, (unknown), (unknown), Wei Qiao, (unknown), Xihai Zhao, Liping Chen	3
14	Augmented corticotomy-assisted presurgical orthodontic treatment to prevent alveolar bone loss in patients with skeletal Class III malocclusion 2022 ·American Journal of Orthodontics and Dentofacial Orthopedics ·(unknown), (unknown), Li Xu, Jianxia Hou, Xiaoxia Wang, Weiran Li, Xiaotong Li	12
15	Predictive Effect of Triglyceride Glucose−Related Parameters, Obesity Indices, and Lipid Ratios for Diabetes in a Chinese Population: A Prospective Cohort Study 2022 ·Frontiers in Endocrinology ·Xiaotong Li, Mengzi Sun, Yixue Yang, Nan Yao, Shoumeng Yan, Ling Wang, Wenyu Hu, (unknown), Yuxiang Wang, Bo Li	75
16	Delays in care seeking, diagnosis and treatment of patients with pulmonary tuberculosis in Hubei, China 2019 ·International Health ·(unknown), Yeqing Tong, Xiaoxv Yin, Lei Qiu, Na Sun, Yuxin Zhao, Dandan Li, Xiaotong Li, Yanhong Gong	15
17	Efficacy and safety of saxagliptin in patients with type 2 diabetes: A systematic review and meta-analysis 2018 ·PLoS ONE ·Peng Men, Xiaotong Li, Huilin Tang, Suodi Zhai	25
18	Development and validation of an algorithm to identify drug-induced anaphylaxis in the Beijing Pharmacovigilance Database 2018 ·International Journal of Clinical Pharmacy ·Ying Zhao, Haidong Lu, (unknown), Xiaotong Li, John C.K. Hui, Huilin Tang, Suodi Zhai, Lulu Sun, Tiansheng Wang	6
19	Ideas and exploration on acupuncture treatment of premature ovarian failure 2016 ·Xiaotong Li, (unknown), (unknown), (unknown)	2
20	[Theory and application regarding "stage by stage" acupuncture for diminished ovarian reserve]. 2016 ·PubMed ·Xiaotong Li, Baoyan Liu, (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact